Thiazide Diuretics Market Size & Share, by Application (Hypertension, Cardiovascular Disorder, Hepatic Disorders, Kidney Disorders); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3318
  • Published Date: Jan 03, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Thiazide Diuretics Market size is anticipated to reach USD 234 Million by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024-2036. In the year 2023, the Industry size of thiazide diuretics was over USD 104 Million. The increasing prevalence of hypertension drives the demand for thiazide diuretics. These medications effectively reduce blood pressure by eliminating excess fluid and sodium, making them a primary choice in managing hypertension and its associated risks. With a systolic blood pressure of more than 130 mmHg or a diastolic blood pressure of more than 80 mmHg, or with hypertension medication, over half of adults (48.1%, 119.9 million) have hypertension. Approximately 1 in 4 persons with hypertension (22.5 percent, 27.0 million) have their hypertension under control.

Further, the predicted prevalence of hypertension at the CCG level varies from 16% to 33.8%. Hypertension in general practitioner practices falls between 18.8% to 31%, with the top and worst 10% of practices excluded.


Thiazide Diuretics Market
Get more information on this report: Request Free Sample PDF

Thiazide Diuretics Sector: Growth Drivers and Challenges

Growth Drivers                    

  • Emerging Economies- Market expansion in developing nations with a focus on accessible healthcare boosts demand for cost-effective medications like thiazide diuretics, fostering thiazide diuretics market growth.
  • Awareness Programs- Increased awareness about hypertension management fosters demand for thiazide diuretics among patients and healthcare providers, driving market growth
  • Rise in precision Medication- Precision medicine is a relatively new area of medicine that bases therapy recommendations on a patient's lifestyle, genetic composition, and environment. The success in treating and preventing chronic diseases has led to a rise in the popularity of precision medicine. This makes it possible for medical professionals and academics to forecast illness prevention and treatment more accurately. Personalized or individualized medicine are other terms for precision medicine. Treatment of epigenetics mutation within healthy cells is its main goal. Compared to conventional medications, precision medicine has a lower risk of side effects and can be utilized for tailored treatment.
  • Government Initiatives – Healthcare policies favoring cost- effective treatments promote thiazide diuretics use, influencing thiazide diuretics market growth due to their affordability.

Challenges                           

  • Changing Treatment Guidelines- Evolving clinical guidelines and recommendations for hypertension management might influence the choice of medications. If thiazide diuretics are no longer prioritized as first-line treatments, their thiazide diuretics market demand could decrease.
  • Limited Efficacy in certain Patient Groups.
  • Competition from other classes of antihypertensive drugs.

Thiazide Diuretics Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

 7%

Base Year Market Size (2023)

 USD  104 Million

Forecast Year Market Size (2036)

 USD 234 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Thiazide Diuretics Segmentation

Application (Hypertension, Cardiovascular Disorder, Hepatic Disorders, Kidney Disorders)

The hypertension segment is estimated to account for 48% of the global thiazide diuretics market during the forecast period. The rise in the number of hypertension drugs delivered through retail pharmacies and the rise in the number of retail pharmacies in highly developed countries, create opportunities. Further, the sedentary lifestyle adopted by the population, has resulted in cardiovascular diseases, providing opportunities for the segment’s growth. 

Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

The retail pharmacies segment in the thiazide diuretics market is expected to hold a major revenue share. The retail pharmacies segment has undergone a technological revolution that has fuelled expansion and improved client satisfaction. Prescription filling procedures are made easier by pharmacy automation systems, clients can get prescriptions online, and telemedicine services enable remote medication delivery and consultation. In addition to increasing the effectiveness of retail pharmacies, these technological advancements draw in more clients, which helps the industry grow.

Our in-depth analysis of the global market includes the following segments:

         Application

  • Hypertension
  •  Cardiovascular Disorder
  •  Hepatic Disorders
  •  Kidney Disorders

         Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Thiazide Diuretics Industry - Regional Synopsis

North American Market Forecast

North America thiazide diuretics market is poised to hold the largest revenue share, amounting to 45%. The market has seen consistent growth due to the prevalent cases of hypertension and related cardiovascular diseases. Thiazide diuretics, such as hydrochlorothiazide (HCTZ) and chlorthalidone, have been among the primary choices for managing hypertension in the region. Factors contributing to this market growth include a high incidence of hypertension among the population, lifestyle-related health issues, and an aging demographic.

APAC Market Statistics

The Asia Pacific region represents a significant and growing market for thiazide diuretics. With a rising prevalence of hypertension and related cardiovascular diseases across countries like China, India, Japan, and others, the demand for effective antihypertensive medications like thiazide diuretics is steadily increasing. Factors such as lifestyle changes, urbanization, and an aging population contribute to this growth.

Research Nester
Thiazide Diuretics Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Thiazide Diuretics Landscape

top-features-companies
    • Pfizer Inc. 
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
    • Merck & Co., Inc.
    • Sanofi 
    • Bayer AG
    • Centaur Pharmaceuticals Private Limited
    • Validus Pharmaceuticals LLC
    • Teva Pharmaceutical Industries Ltd.
    • Novartis Pharmaceuticals Corporation
    • Boehringer Ingelheim International GmbH
    •  Cipla Inc.
    •  scPharmaceuticals, Inc.

In-the-news

In The News

  • December,2021- Arena Pharmaceuticals, Inc. and Pfizer Inc. announced that they had reached a final agreement whereby Pfizer will purchase Arena, a clinical stage business creating novel therapeutic treatments for the management of several immuno-inflammatory illnesses. Pfizer will purchase all of Arena's outstanding shares under the terms of the agreement for $100 per share in an all-cash deal, for a total equity value of roughly $6.7 billion. Both firms' boards of directors have overwhelmingly approved the deal.
     
  • May,2019- In order to promote clinical research in pulmonary hypertension (PH), with an emphasis on pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), Bayer U.S. announced the creation of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards. Over the course of a two-year cycle, the initiative will provide grants totaling up to $1 million.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3318
  • Published Date: Jan 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of hypertension, progressive government policies, Adoption of precision medicine are some of the major growth drivers for the thiazide diuretics market.

The market size of thiazide diuretics is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024-2036.

The major players in the market are Pfizer Inc., Merck & Co., Inc., Sanofi, Bayer AG, Centaur Pharmaceuticals Private Limited, Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Novartis Pharmaceuticals Corporation, Boehringer Ingelheim International GmbH, Cipla Inc. and others.

The hypertension segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Thiazide Diuretics Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying